EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

The Impact of New Sacral Neuromodulation Technologies on the Quality of Life of Patients with Refractory Overactive Bladder: A Mini-Review

Mohammed Amine Elafari, Mohammed Amine Bibat, Mamad Ayoub, Amine Slaoui, Tarik Karmouni, Abdelatif Koutani, Khalid Elkhader

Journal of Clinical Nephrology · 16.04.2026 · 039-043

DOI: 10.29328/journal.jcn.1001174 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Clinical Nephrology, online erschienen am 16.04.2026. Verfasst von Mohammed Amine Elafari und 6 weiteren Autor:innen. Die Arbeit nennt 17 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Overactive bladder (OAB) affects millions of patients worldwide and significantly impairs quality of life. For patients with refractory OAB who fail conservative and pharmacological therapies, sacral neuromodulation (SNM) has emerged as a highly effective minimally invasive treatment option. Recent technological advances, particularly the development of rechargeable SNM systems with extended longevity and miniaturized designs, have transformed the therapeutic landscape. This mini review examines the impact of new SNM technologies on patient quality of life, comparing traditional non-rechargeable devices with newer rechargeable systems, and evaluating clinical efficacy, safety profiles, and patient satisfaction outcomes. Evidence demonstrates that both traditional and novel SNM systems provide sustained improvements in OAB symptoms and quality of life, with success rates ranging from 67-90% at long-term follow-up. Rechargeable systems offer the advantage of extended device longevity (15+ years) and reduced need for replacement surgeries, though recent data suggest potentially higher revision rates related to charging difficulties. Quality of life improvements are consistently demonstrated across multiple validated instruments, with patients reporting significant reductions in symptom burden and enhanced satisfaction. This review synthesizes current evidence to assist clinicians in navigating the evolving SNM landscape and selecting the most appropriate technology for patients with refractory OAB.

Zitieren

APA

Elafari, M. A., Bibat, M. A., Ayoub, M., Slaoui, A., Karmouni, T., Koutani, A., & Elkhader, K. (2026). The Impact of New Sacral Neuromodulation Technologies on the Quality of Life of Patients with Refractory Overactive Bladder: A Mini-Review. Journal of Clinical Nephrology, 039-043. https://doi.org/10.29328/journal.jcn.1001174

Vancouver

Elafari MA, Bibat MA, Ayoub M, Slaoui A, Karmouni T, Koutani A, et al. The Impact of New Sacral Neuromodulation Technologies on the Quality of Life of Patients with Refractory Overactive Bladder: A Mini-Review. Journal of Clinical Nephrology. 2026:039-043. doi:10.29328/journal.jcn.1001174

BibTeX
@article{Elafari2026,
  author = {Elafari, Mohammed Amine and Bibat, Mohammed Amine and Ayoub, Mamad and Slaoui, Amine and Karmouni, Tarik and Koutani, Abdelatif and Elkhader, Khalid},
  title = {The Impact of New Sacral Neuromodulation Technologies on the Quality of Life of Patients with Refractory Overactive Bladder: A Mini-Review},
  journal = {Journal of Clinical Nephrology},
  year = {2026},
  pages = {039--043},
  doi = {10.29328/journal.jcn.1001174}
}
Kostenlos starten →